Nichols & Pratt Advisers LLP MA Sells 260 Shares of Stryker Co. (NYSE:SYK)

Nichols & Pratt Advisers LLP MA lowered its holdings in shares of Stryker Co. (NYSE:SYK) by 0.4% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 65,695 shares of the medical technology company’s stock after selling 260 shares during the period. Nichols & Pratt Advisers LLP MA’s holdings in Stryker were worth $13,521,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in SYK. D.B. Root & Company LLC grew its holdings in Stryker by 3.0% in the 2nd quarter. D.B. Root & Company LLC now owns 1,724 shares of the medical technology company’s stock worth $354,000 after acquiring an additional 50 shares during the last quarter. Independence Bank of Kentucky grew its holdings in Stryker by 4.9% in the 1st quarter. Independence Bank of Kentucky now owns 1,180 shares of the medical technology company’s stock worth $233,000 after acquiring an additional 55 shares during the last quarter. Benedict Financial Advisors Inc. lifted its position in shares of Stryker by 1.1% in the 1st quarter. Benedict Financial Advisors Inc. now owns 5,235 shares of the medical technology company’s stock worth $1,034,000 after purchasing an additional 57 shares during the period. Berman Capital Advisors LLC lifted its position in shares of Stryker by 11.1% in the 1st quarter. Berman Capital Advisors LLC now owns 571 shares of the medical technology company’s stock worth $112,000 after purchasing an additional 57 shares during the period. Finally, Bailard Inc. lifted its position in shares of Stryker by 0.6% in the 2nd quarter. Bailard Inc. now owns 9,219 shares of the medical technology company’s stock worth $1,895,000 after purchasing an additional 57 shares during the period. 74.14% of the stock is currently owned by institutional investors.

Several research firms have recently commented on SYK. Wells Fargo & Co raised their target price on shares of Stryker from $219.00 to $228.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 2nd. BTIG Research reaffirmed a “buy” rating and issued a $228.00 target price on shares of Stryker in a research report on Monday, July 29th. Morgan Stanley raised their target price on shares of Stryker from $218.00 to $230.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 16th. Svb Leerink reaffirmed an “outperform” rating on shares of Stryker in a research report on Wednesday, July 10th. Finally, Cantor Fitzgerald raised their target price on shares of Stryker from $190.00 to $230.00 and gave the stock a “neutral” rating in a research report on Friday, July 26th. Five analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $214.89.

NYSE SYK traded up $0.98 during trading hours on Tuesday, reaching $219.62. 248,317 shares of the company’s stock traded hands, compared to its average volume of 1,075,709. Stryker Co. has a 52-week low of $144.75 and a 52-week high of $222.59. The firm has a market cap of $81.79 billion, a PE ratio of 30.04, a PEG ratio of 2.63 and a beta of 0.85. The firm has a 50-day simple moving average of $211.51 and a 200 day simple moving average of $195.32. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.07 and a quick ratio of 1.26.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, July 25th. The medical technology company reported $1.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.93 by $0.05. Stryker had a net margin of 24.99% and a return on equity of 25.98%. The company had revenue of $3.65 billion during the quarter, compared to analysts’ expectations of $3.60 billion. During the same period last year, the company posted $1.76 EPS. Stryker’s revenue was up 9.9% on a year-over-year basis. Sell-side analysts forecast that Stryker Co. will post 8.21 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 31st. Investors of record on Monday, September 30th will be given a dividend of $0.52 per share. The ex-dividend date is Friday, September 27th. This represents a $2.08 dividend on an annualized basis and a yield of 0.95%. Stryker’s dividend payout ratio (DPR) is currently 28.45%.

In other Stryker news, Director Srikant M. Datar sold 350 shares of the firm’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $215.00, for a total transaction of $75,250.00. Following the completion of the sale, the director now directly owns 6,844 shares in the company, valued at approximately $1,471,460. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Timothy J. Scannell sold 4,666 shares of the firm’s stock in a transaction dated Tuesday, June 18th. The shares were sold at an average price of $197.68, for a total transaction of $922,374.88. Following the sale, the insider now owns 155,347 shares of the company’s stock, valued at $30,708,994.96. The disclosure for this sale can be found here. Over the last three months, insiders have sold 20,447 shares of company stock valued at $4,262,634. 7.20% of the stock is currently owned by corporate insiders.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Recommended Story: How is a Moving Average Calculated?

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.